Related Experiment Video

Updated: Nov 10, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.1K

The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma

Sara Lettieri1, Chandra Bortolotto2, Francesco Agustoni3

  • 1Department of Medical Sciences and Infective Diseases, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia Medical School, 27100 Pavia, Italy.

Journal of Clinical Medicine
|April 3, 2021
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a rare cancer linked to asbestos. Molecular epidemiology offers new tools for early detection and better treatment strategies for this aggressive disease.

Area of Science:

  • Oncology
  • Environmental Health
  • Molecular Epidemiology

Background:

  • Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer primarily affecting the lung's pleural lining.
  • MPM is strongly associated with exposure to biopersistent fibers, predominantly asbestos (80% of cases), and other environmental zeolites in specific regions.
  • Current targeted therapies effective in other cancers have shown limited success in MPM, highlighting the need for novel approaches.

Purpose of the Study:

  • To review the natural evolution of malignant pleural mesothelioma.
  • To explore the emerging field of molecular epidemiology in MPM research.
  • To identify new tools for screening exposed individuals and improving diagnostic and therapeutic strategies.

Main Methods:

  • Discussion of the natural history and epidemiological associations of MPM.
  • Focus on the application of molecular epidemiology principles.
  • Review of innovative endpoints, genetic damage quantification, and genetic susceptibility assessment.

Main Results:

  • Molecular profiling is revealing novel biomarkers and actionable targets for MPM.
  • Molecular epidemiology provides a framework for understanding disease development and risk.
  • The study emphasizes the potential for improved screening and treatment strategies.

Conclusions:

  • Understanding MPM's molecular epidemiology is crucial for advancing patient care.
  • Novel tools derived from molecular insights can enhance screening and therapeutic development.
  • Further research in molecular epidemiology holds promise for combating this orphan disease.
Keywords:
geneticsmesotheliomamolecular epidemiologypersonalized medicine

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.1K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.5K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
409
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
378